AFP and hepatocellular carcinoma: For HBV-HCC patients with AFP levels less than 20 ng/ml, the overall SEN and SPE of circulating miRNAs were 0.85 (95% CI: 0.79–0.90) and 0.74 (95% CI: 0.63–0.82), respectively.